Sysmex Corporation’s board has approved a share repurchase program and subsequent cancellation of the repurchased stock as part of its mid-term management plan through March 2029. The initiative is ...
In this installment, we introduce the company Sysmex. We will share how we are continuing our dialogue with this company ...
HENDERSON, Nev., June 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces a collaboration with Sysmex (TYO: 6869), a leader ...
BALTIMORE, Feb. 22, 2022 /PRNewswire/ -- Sysmex Inostics, a global leader in the liquid biopsy revolution for oncology, will introduce HNSCC-SEQ, a highly sensitive Plasma-Safe-SeqS and Next ...
BALTIMORE, April 10, 2021 /PRNewswire/ -- Sysmex Inostics, Inc., a global leader of the liquid biopsy revolution for oncology, is presenting the poster "Clinical evaluation of NGS-based liquid biopsy ...
Sysmex has put investors through a long, grinding stretch, with the share price falling 57.8% over the past 5 years. The obvious question now is whether the current ¥1,855 level is properly backed by ...
TOKYO & KOBE, Japan--(BUSINESS WIRE)--Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have entered into an agreement ...
TOKYO & KOBE, Japan--(BUSINESS WIRE)--Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announce that ...
Newswise — Chicago – July 9, 2024 – Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and information systems, today announced ...
Newswise — Chicago – July 16, 2025 – Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, will be ...
"Sysmex's hemostasis solutions bring together advanced technology, trusted reagents and award-winning service to provide laboratories with reliable results for diagnosing patients suffering from ...
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on. Benchmark your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results